TIGIT antibody with PVR competitive ability enhances cancer immunotherapy and capable of eliciting anti-tumour immune memory. Yu H, Jin S, Zeng M, Yang Z, et al. Br J Cancer 2025;133:743-755.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yu H, Jin S, Zeng M, Yang Z, et al. TIGIT antibody with PVR competitive ability enhances cancer immunotherapy and capable of eliciting anti-tumour immune memory. Br J Cancer 2025;133:743-755.
PMID: 40394151